Prism Medico & Pharmacy
Quarterly Financials Mar 2016
Jun 2016
Mar 2017
Jun 2017
Sept 2017
Dec 2017
Mar 2018
Jun 2018
Sept 2018
Dec 2018
Mar 2019
Jun 2019
Sept 2019
Dec 2019
Revenue 0
0
3
12
6
5
0
6
15
17
17
9
7
10
Expenses 0
0
2
11
6
5
1
5
15
17
17
9
6
10
EBITDA 0
-0
1
1
0
0
-0
1
0
0
-1
0
0
0
Operating Profit % 0 %
0 %
26 %
7 %
1 %
1 %
-50 %
7 %
2 %
1 %
-5 %
2 %
3 %
0 %
Depreciation 0
0
0
0
0
0
0
0
0
0
0
0
0
0
Interest 0
0
0
0
0
0
0
0
0
0
0
0
0
0
Profit Before Tax 0
-0
1
1
-0
-0
-0
0
0
0
-1
0
0
0
Tax 0
0
0
0
0
0
0
0
0
0
0
0
0
0
Net Profit 0
-0
1
1
-0
-0
-0
0
0
0
-1
0
0
0
EPS in ₹ 0.00
-0.53
0.90
1.12
-0.23
-0.19
-0.70
0.62
0.46
0.24
-1.21
0.21
0.15
-0.07
Above figures are in Rs. Crores Balance Sheet 2017
2018
2019
Total Assets 17
16
21
Fixed Assets 10
9
9
Current Assets 7
4
11
Capital Work in Progress 0
0
0
Investments 0
3
1
Other Assets 7
4
11
Total Liabilities 17
16
21
Current Liabilities 1
3
8
Non Current Liabilities 3
0
0
Total Equity 13
13
13
Reserve & Surplus 7
7
7
Share Capital 6
6
6
Above figures are in Rs. Crores Cash Flow 2017
2018
2019
Net Cash Flow 0
-1
-1
Investing Activities 0
-3
0
Operating Activities 0
4
-0
Financing Activities 0
-2
-1
Above figures are in Rs. Crores % Holding Mar 2021
Jun 2021
Sept 2021
Dec 2021
Mar 2022
Jun 2022
Sept 2022
Dec 2022
Mar 2023
Jun 2023
Sept 2023
Dec 2023
Mar 2024
Jun 2024
Sept 2024
Dec 2024
Mar 2025
Jun 2025
Sept 2025
Dec 2025
Promoter 38.02 %
29.06 %
23.93 %
23.93 %
23.93 %
23.93 %
23.93 %
23.93 %
23.93 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
25.00 %
FIIs 0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
DIIs 0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Government 0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
0.00 %
Public / Retail 54.60 %
59.85 %
69.11 %
68.82 %
67.22 %
67.65 %
64.91 %
64.89 %
61.78 %
63.66 %
64.02 %
65.76 %
67.23 %
67.30 %
65.77 %
65.36 %
66.07 %
65.26 %
65.26 %
65.63 %
Others 7.38 %
11.09 %
6.95 %
7.25 %
8.85 %
8.42 %
11.16 %
11.18 %
14.29 %
11.34 %
10.98 %
9.24 %
7.77 %
7.70 %
9.23 %
9.64 %
8.93 %
9.74 %
9.74 %
9.37 %
No of Share Holders 1,243
1,900
2,790
3,731
4,245
4,168
3,890
3,328
3,558
3,610
3,465
3,650
3,792
3,866
4,107
4,178
4,302
4,306
4,315
4,306
Board Meeting Intimation for Consideration Approval And Taking On Record The Unaudited Standalone Financial Results Of The Company Along With The Limited Review Report For The Quarter Ended 31St December 2025. 8 hrs ago Undertaking Of Functional Website 8 days ago Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Jan 16, 2026 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Jan 14, 2026 Compliance-57 (5) : intimation after the end of quarter Jan 02, 2026 Intimation Under Regulation 57(4) Of SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Dec 31, 2025 Closure of Trading Window Dec 24, 2025 Revised Outcome Of The Board Meeting Held On 14Th November 2025. Nov 21, 2025 Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Nov 14, 2025 Board Meeting Intimation for Intimation Of Board Meeting. Nov 06, 2025 Undertaking Of Functional Website. Oct 27, 2025 Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Oct 17, 2025 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Oct 13, 2025 Shareholder Meeting / Postal Ballot-Scrutinizers Report Oct 01, 2025 Compliance-57 (5) : intimation after the end of quarter Oct 01, 2025 Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Oct 01, 2025 Closure of Trading Window Oct 01, 2025 Regulation 30(2) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 - Proceedings Of 23Rd Annual General Meeting Held On 30Th September 2025. Sep 30, 2025 Outcome Of 23Rd Annual General Meeting Held On 30Th September 2025 At 11:30 A.M. Through Video Conferencing/Other Audio Visual Means. Sep 30, 2025 Revised Outcome Of Board Meeting Dated 14Th August 2025. Sep 12, 2025 Reg. 34 (1) Annual Report. Sep 06, 2025 Intimation Of Record Date. Sep 05, 2025 Intimation Of Book Closure. Sep 05, 2025 Notice Of 23Rd Annual General Meeting. Sep 05, 2025 Annual Report For The Financial Year 2024-2025. Sep 05, 2025 Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Sep 05, 2025 Board Meeting Intimation for Intimation Of Board Meeting. Sep 01, 2025 Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Aug 14, 2025 Announcement under Regulation 30 (LODR)-Meeting Updates Aug 07, 2025 Board Meeting Intimation for Meeting To Be Held On Thursday The 14Th Day Of August 2025 At 01:30 P.M. At The Registered Office Of The Company I.E. Suketi Road Kala Amb Sirmaur Himachal Pradesh-173030. Aug 07, 2025 Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Aug 04, 2025 Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Jul 16, 2025 Undertaking Of Functional Website. Jul 15, 2025 Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Jul 15, 2025 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Jul 14, 2025 Revised Outcome Of Board Meeting Dated 28Th May 2025. Jul 01, 2025 Compliance-57 (5) : intimation after the end of quarter Jul 01, 2025 Intimation Under Regulation 57(4) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Jun 30, 2025 Closure of Trading Window Jun 30, 2025 Details Of Related Party Transactions (RPTS) As Per Regulation 23(9) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. May 28, 2025 Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. May 28, 2025 Board Meeting Intimation for Intimation Of Board Meeting As Per Regulation 29(1) Of SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. May 20, 2025 Submission Of Certificate Under Regulation 40(9) Of The Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 For The Financial Year Ended 31St March 2025. Apr 25, 2025 Board Meeting Outcome for Outcome Of The Board Meeting - Disclosure Under Regulation 30 Of The SEBI (Listing Obligations And Disclosure Requirements) Regulations 2015. Apr 15, 2025 Confirmation Regarding Non-Applicability Of Large Corporate Entity Framework. Apr 09, 2025 Submission Of Compliance Certificate As Per Regulation 7(3) Of Securities And Exchange Board Of India (Listing Obligations And Disclosure Requirements) Regulations 2015 During The Financial Year Ended 31St March 2025. Apr 09, 2025 Undertaking Of Functional Website. Apr 09, 2025 Disclosure Under Regulation 31(4) Of SEBI (Substantial Acquisition Of Shares And Takeovers) Regulations 2011 For The Financial Year Ended 31St March 2025. Apr 08, 2025 Investor Complaints As Per Regulation 13(3) Of The SEBI (Listing Obligation And Disclosure Requirements) Regulations 2015. Apr 07, 2025 Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations 2018 Apr 07, 2025 RSI(14)
Neutral
54.08
ATR(14)
Volatile
1.38
STOCH(9,6)
Neutral
72.06
STOCH RSI(14)
Overbought
93.43
MACD(12,26)
Bullish
0.24
ADX(14)
Weak Trend
17.33
UO(9)
Bearish
51.47
ROC(12)
Uptrend And Accelerating
4.83
WillR(14)
Neutral
-42.80